Grants and Contributions:
Title:
Clinical Research Trial of Keep Klear Transparent Microbicidal Coating Technology at Eastern Health Facility
Agreement Number:
1006230
Agreement Value:
$273,339.00
Agreement Date:
Apr 3, 2023 - Jun 30, 2025
Description:
Keep Klear is the first technology of its kind to be approved for clinical research trials in Canada, which is set to take place with Eastern Health. The clinical research trial is divided into 3 phases, where this innovative microbicidal technology is subjected to diversified test conditions to understand (a) its integration (b) its effectiveness (c) its impact on patient outcomes/readmissions.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
St. John's, Newfoundland & Labrador, CA A1E 6B5
Reference Number:
172-2023-2024-Q1-1006230
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
780785119
Recipient Type:
For-profit organization
Additional Information:
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 91 days. The total amended value is 73,339 dollars.
Amendment Date
Jan 14, 2025
Recipient's Operating Name:
Polyamyna
Recipient's Legal Name:
Polyamyna Nanotech Inc.
Federal Riding Name:
St. John's South--Mount Pearl
Federal Riding Number:
10007
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
3255
Amendments: